Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Wave Life Sciences (WVE) Share-based Compensation (2016 - 2026)

Wave Life Sciences (WVE) has disclosed Share-based Compensation for 12 consecutive years, with $9.1 million as the latest value for Q1 2026.

  • For Q1 2026, Share-based Compensation rose 82.98% year-over-year to $9.1 million; the TTM value through Mar 2026 reached $29.1 million, up 91.17%, while the annual FY2025 figure was $25.0 million, 90.04% up from the prior year.
  • Share-based Compensation hit $9.1 million in Q1 2026 for Wave Life Sciences, up from $7.4 million in the prior quarter.
  • Across five years, Share-based Compensation topped out at $9.1 million in Q1 2026 and bottomed at $2.3 million in Q3 2023.
  • Average Share-based Compensation over 5 years is $4.4 million, with a median of $3.5 million recorded in 2024.
  • Year-over-year, Share-based Compensation skyrocketed 155.33% in 2022 and then tumbled 65.34% in 2023.
  • Wave Life Sciences' Share-based Compensation stood at $2.9 million in 2022, then decreased by 19.09% to $2.4 million in 2023, then soared by 37.93% to $3.2 million in 2024, then soared by 126.63% to $7.4 million in 2025, then grew by 23.27% to $9.1 million in 2026.
  • According to Business Quant data, Share-based Compensation over the past three periods came in at $9.1 million, $7.4 million, and $6.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.